← All Quest Diagnostics INC filings

Quest Diagnostics INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NYSE
DGX
Quest Diagnostics INC
10-K: Quest Diagnostics Reports Strong 2025 Growth, Boosts Dividend
Quest Diagnostics reported robust financial results for 2025, driven by significant revenue growth, strategic acquisitions, and increased shareholder returns, while navigating evolving healthcare landscapes.
NYSE
DGX
Quest Diagnostics INC
10-K: Quest Diagnostics Reports Fiscal Year 2024 Results, Highlights Strategic Acquisitions and Dividend Increase
Quest Diagnostics announces its financial results for the fiscal year ended December 31, 2024, showcasing strategic growth through acquisitions and increased shareholder returns.
NYSE
DGX
Quest Diagnostics INC
10-K: Quest Diagnostics Reports Full Year 2023 Results, Navigates Evolving Healthcare Landscape
Quest Diagnostics' 2023 annual report highlights a year of strategic acquisitions and operational adjustments amidst a changing healthcare environment, with net revenues reaching $9.3 billion.